An Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy

dc.contributor.authorSevindik, Omur Gokmen
dc.contributor.authorOzkurt, Zubeyde Nur
dc.contributor.authorBoga, Can
dc.contributor.authorBesisik, Sevgi Kalayoglu
dc.contributor.authorIpek, Yildiz
dc.contributor.authorGeduk, Ayfer
dc.contributor.authorOzsan, Guner Hayri
dc.date.accessioned2026-08-12T18:11:44Z
dc.date.issued2021
dc.departmentFırat Üniversitesi
dc.description63rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) -- DEC 11-14, 2021 -- Atlanta, GA
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipAmer Soc Hematol
dc.identifier.doi10.1182/blood-2021-150175
dc.identifier.issn0006-4971
dc.identifier.issn1528-0020
dc.identifier.orcid0000-0002-2281-5978
dc.identifier.orcid0000-0003-2952-2286
dc.identifier.urihttps://doi.org/10.1182/blood-2021-150175
dc.identifier.urihttps://hdl.handle.net/11508/63804
dc.identifier.volume138
dc.identifier.wosWOS:000835740102199
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofBlood
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleAn Interim Analysis of the Turkish Myeloma Registry Among the Patients Who Have Received up to Two Lines of Therapy
dc.typeConference Object

Dosyalar